Rubric Capital Management LP 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 06:06 am Sale | 2023-12-31 | 13G | Ovid Therapeutics Inc. OVID | Rubric Capital Management LP | 5,315,969 7.520% | -1,512,096 (-22.15%) | Filing |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Ovid Therapeutics Inc. OVID | Rubric Capital Management LP | 6,828,065 9.690% | 6,828,065 (New Position) | Filing |